Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26255,119,1.06 [0.78-1.45],0.6921450132692184
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",26989,200,1.21 [0.96-1.52],0.1144225575991945
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26710,1319,1.11 [1.01-1.21],0.0308311288396917
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,27016,466,1.05 [0.90-1.23],0.5506396354711236
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26170,3457,1.11 [1.05-1.18],0.0003440350601216
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26399,2852,1.14 [1.07-1.21],4.137958621165146e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,26734,1366,1.16 [1.06-1.27],0.0012713014230195
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,26913,91,1.13 [0.80-1.59],0.4972987842803539
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25172,805,1.22 [1.08-1.37],0.0009034989853735
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24355,947,1.19 [1.08-1.33],0.0009197065095609
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24365,254,1.36 [1.12-1.65],0.0022458716539248
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18968,1663,1.15 [1.06-1.25],0.0007497517726534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24149,369,1.34 [1.14-1.58],0.0005032403355312
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26953,1585,1.14 [1.05-1.24],0.0017902490261897
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Mycoses,27078,528,1.09 [0.95-1.26],0.2292007402211369
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26327,936,1.11 [1.00-1.24],0.0547738752543476
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27023,887,1.18 [1.06-1.32],0.0026150648710148
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25568,200,1.22 [0.96-1.54],0.0973434472823894
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27138,47,1.12 [0.69-1.81],0.6469363589454531
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26915,779,1.22 [1.08-1.37],0.0010014002693542
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,26902,80,1.16 [0.79-1.70],0.4375988176054542
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27040,190,1.44 [1.15-1.80],0.0016874507517783
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27022,172,1.36 [1.07-1.74],0.0119724328434806
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25735,344,1.10 [0.91-1.31],0.323299839588632
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,25650,259,1.26 [1.03-1.55],0.0228141858659576
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,25494,126,0.95 [0.70-1.30],0.7564196120360693
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27113,34,0.93 [0.52-1.67],0.8047980337743345
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27065,153,1.04 [0.78-1.38],0.8113297657457589
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral warts,26959,47,0.99 [0.58-1.68],0.9684750167464644
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],26985,73,1.06 [0.71-1.59],0.7744075287526185
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,26869,240,1.02 [0.82-1.28],0.8416966587371089
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27034,70,1.34 [0.91-1.97],0.1407874041982169
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27033,70,0.98 [0.65-1.48],0.9402460710231224
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26853,1207,1.10 [0.99-1.21],0.0660118389873005
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of meninges,27110,78,1.60 [1.16-2.22],0.0047509399211092
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27073,63,0.78 [0.48-1.26],0.3119608847194239
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27104,132,1.13 [0.84-1.51],0.4181969106214902
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm of ovary,27056,171,1.29 [1.00-1.66],0.0517185499172498
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27116,271,1.01 [0.82-1.25],0.9159955614856056
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Caecum,27122,248,1.04 [0.83-1.30],0.7274729564961744
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27050,60,1.64 [1.15-2.34],0.0060232023341882
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,27121,154,1.06 [0.81-1.39],0.6839288511804423
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Rectum,27083,279,1.19 [0.97-1.46],0.0874172603373285
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27033,491,1.19 [1.02-1.39],0.022627398632314
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27118,295,1.10 [0.90-1.34],0.3478060369065674
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Carcinoma in situ of breast,22008,134,1.03 [0.75-1.40],0.8682378714029048
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22099,164,1.13 [0.86-1.49],0.3735065489980506
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22075,32,1.93 [1.20-3.12],0.0071347636131927
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22110,67,1.06 [0.69-1.63],0.7876914053574308
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27071,135,0.94 [0.70-1.28],0.7105066105213067
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Haemangioma, any site",27072,134,0.94 [0.69-1.28],0.6904484186101294
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Leiomyoma of uterus,26159,574,0.90 [0.77-1.05],0.1723233241626225
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lung cancer and mesothelioma,19472,310,1.98 [1.64-2.38],5.765421011803533e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Lymphoid leukaemia,22081,38,1.69 [1.04-2.73],0.0324004858981093
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22219,176,1.00 [0.76-1.31],0.9824083803833062
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22152,109,0.95 [0.68-1.33],0.7571059358667238
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22228,185,1.14 [0.89-1.47],0.306870756775045
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22112,69,0.70 [0.44-1.10],0.1256981999021557
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22113,70,0.99 [0.66-1.49],0.97772167855796
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22096,53,1.06 [0.66-1.68],0.8201446808364571
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22182,139,1.28 [0.97-1.68],0.0825667597810841
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22145,102,0.74 [0.51-1.06],0.1030896100953104
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22121,78,1.23 [0.84-1.79],0.2828378444321056
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22085,42,1.08 [0.63-1.85],0.7930116570170511
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22124,81,1.79 [1.32-2.43],0.0001641536101027
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi,26882,227,0.97 [0.77-1.24],0.8297602171185001
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanocytic naevi of trunk,27093,78,0.95 [0.63-1.44],0.8254489894839928
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Melanoma in situ,22078,88,0.97 [0.66-1.43],0.8925468831965002
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22122,79,1.15 [0.78-1.70],0.4783786225039655
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22194,151,1.31 [1.00-1.71],0.0482434470606745
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22272,229,1.46 [1.22-1.75],3.741631319371609e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22135,92,1.58 [1.16-2.16],0.0034606473159765
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Other benign neoplasms of skin,26913,163,1.31 [1.01-1.70],0.039811951198285
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22966,923,1.09 [0.97-1.23],0.1307444339970744
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23005,962,1.08 [0.96-1.21],0.189611999112423
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26834,362,1.06 [0.88-1.26],0.5555219936146907
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25145,105,1.12 [0.81-1.55],0.5019325512889955
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,26541,69,1.42 [0.98-2.07],0.0650005674112398
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26135,2935,1.11 [1.04-1.18],0.0012341543068545
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,25510,36,0.74 [0.40-1.36],0.3364278903115587
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,26739,48,1.17 [0.72-1.90],0.5242678034816339
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26557,1517,1.16 [1.07-1.26],0.0006209484920482
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26557,1517,1.16 [1.07-1.26],0.0006209484920482
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25108,68,1.79 [1.31-2.44],0.0002511445280346
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26733,1259,1.14 [1.04-1.26],0.005582008973273
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,26812,121,1.30 [0.96-1.75],0.0855254242120604
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,26523,51,1.28 [0.83-1.98],0.2669209559576534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,26529,57,1.45 [0.96-2.18],0.0746510423139911
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,26922,231,1.13 [0.91-1.42],0.2683267190853277
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27023,60,1.26 [0.81-1.95],0.3064262478405444
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",26884,193,1.13 [0.88-1.44],0.3425480229922705
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,25605,131,0.81 [0.59-1.11],0.1818171325754775
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21810,248,1.27 [1.04-1.55],0.0170669145903615
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25721,67,0.88 [0.56-1.40],0.5992812803293255
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25718,64,0.78 [0.55-1.10],0.1513272592627895
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,21615,53,0.78 [0.47-1.30],0.3430073010548778
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,24882,69,1.39 [0.96-2.00],0.0776702647374727
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,24535,247,1.01 [0.81-1.26],0.895290364254794
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",26699,510,1.12 [0.97-1.30],0.1274287482623149
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,26475,286,1.01 [0.82-1.24],0.9048687366631272
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26275,86,0.94 [0.64-1.38],0.752605708729621
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,26741,1928,1.07 [0.99-1.16],0.0715347426381078
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,23994,1878,1.09 [1.01-1.17],0.0364729556683064
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",21621,59,1.60 [1.10-2.33],0.013141590252925
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24066,118,1.01 [0.73-1.39],0.9455869001861582
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21844,282,0.98 [0.80-1.21],0.8781350539279899
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21610,48,1.48 [0.94-2.31],0.0892251662562112
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24692,3130,1.05 [0.99-1.12],0.1335675493388307
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21759,197,1.32 [1.05-1.66],0.0160734505811901
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22096,534,1.13 [0.98-1.31],0.096582569604625
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27033,361,1.08 [0.90-1.30],0.3863898424682376
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,26849,177,0.82 [0.62-1.08],0.1512669897720232
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21664,102,1.06 [0.75-1.51],0.7322489314570914
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",21617,55,1.32 [0.86-2.02],0.2002815842368008
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26256,2308,1.04 [0.97-1.12],0.2723953903710305
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21767,205,1.35 [1.09-1.68],0.0063031952055817
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21774,212,1.24 [0.99-1.55],0.0601932116110825
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22092,530,1.12 [0.96-1.30],0.1366728695035109
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21654,92,1.19 [0.85-1.68],0.311473967391817
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,26839,167,0.73 [0.55-0.98],0.0343580868819416
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22189,627,1.14 [1.00-1.31],0.0518157858806459
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22126,564,1.10 [0.95-1.27],0.2088519424525135
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24358,70,0.85 [0.55-1.30],0.4492646982308341
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26236,4674,1.08 [1.02-1.13],0.0042589113430633
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24025,77,1.32 [0.91-1.91],0.1403971286619826
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24037,89,1.16 [0.81-1.67],0.4132499664772688
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26943,2067,1.13 [1.05-1.22],0.0015132588023242
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26947,2065,1.13 [1.05-1.22],0.0015724060951804
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24029,81,1.54 [1.10-2.16],0.0117981092250986
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,26731,1569,1.10 [1.01-1.19],0.0368951584110481
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23079,1517,1.13 [1.04-1.23],0.0058102903007069
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27123,180,0.97 [0.75-1.25],0.8019838647119426
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26244,55,1.57 [1.06-2.32],0.0236133319262182
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25289,127,0.87 [0.64-1.19],0.384612813279407
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25356,194,0.77 [0.59-1.00],0.0497440958021114
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21824,262,1.16 [0.94-1.43],0.1753877474208483
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25326,138,1.00 [0.74-1.35],0.997979920526981
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1682,45,0.86 [0.51-1.45],0.5729275597558248
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1798,185,0.95 [0.74-1.22],0.681388626823331
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25213,25,1.06 [0.55-2.05],0.853060035612386
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1668,32,0.89 [0.48-1.65],0.7038401609547911
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26655,1467,1.06 [0.97-1.16],0.2169380267231949
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,26529,340,1.10 [0.91-1.32],0.3134865027542113
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,24763,475,1.11 [0.95-1.29],0.2038433382170328
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22288,726,1.11 [0.98-1.26],0.1043333472748047
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27036,232,1.14 [0.92-1.42],0.2440211810763851
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26147,51,1.60 [1.09-2.34],0.0165241305661994
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,25609,865,1.23 [1.11-1.38],0.0001806915596923
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26191,95,1.62 [1.23-2.14],0.0006716746075138
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26129,33,1.28 [0.75-2.19],0.3576024611610655
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26244,148,1.76 [1.42-2.17],2.006123116227807e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17629,1458,1.26 [1.16-1.37],4.4823468052090026e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,AV-block,23757,234,1.18 [0.95-1.47],0.135495260653061
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27096,303,1.19 [0.98-1.43],0.0743039183448021
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16299,128,1.30 [0.99-1.72],0.0597517153597349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23657,134,1.20 [0.91-1.59],0.2001029504393179
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",23602,79,0.99 [0.68-1.46],0.9716787295374818
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27133,34,0.98 [0.56-1.72],0.9523436570341356
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Conduction disorders,24242,719,1.20 [1.06-1.35],0.0047641380337078
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26231,1497,1.21 [1.12-1.32],6.603394119588195e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24376,7174,1.08 [1.03-1.12],0.0003179619187983
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25631,247,1.15 [0.93-1.42],0.2035073548267733
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Endocarditis,23585,62,1.62 [1.13-2.31],0.0079627549086193
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27038,848,1.17 [1.05-1.31],0.005425071405663
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertension,24997,6078,1.03 [0.99-1.08],0.1721043018421169
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25009,6090,1.03 [0.99-1.08],0.1551683518018576
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27025,42,1.28 [0.79-2.09],0.3171650926068004
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19083,164,1.67 [1.37-2.03],4.766874466540874e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19021,102,1.00 [0.72-1.41],0.9794381449657164
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Hypotension,26997,1094,1.21 [1.10-1.34],0.000153539815239
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26384,97,0.94 [0.66-1.35],0.7514439030108144
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26418,1674,1.18 [1.09-1.28],5.391127503816202e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26824,453,1.08 [0.92-1.27],0.326562437955375
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,23819,296,1.25 [1.03-1.50],0.0225835273537514
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26915,600,1.24 [1.09-1.41],0.0012634319316732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25230,486,1.34 [1.17-1.55],4.079831313112734e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27113,85,1.58 [1.16-2.15],0.0038192324814581
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27132,242,1.27 [1.04-1.56],0.0218927639539567
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,25421,37,1.00 [0.55-1.81],0.9958966062526028
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other aneurysm,26151,55,1.41 [0.92-2.18],0.1170722411213142
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,23880,357,1.15 [0.96-1.37],0.1266478683539544
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26159,63,1.33 [0.92-1.93],0.1271640932611346
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26285,189,1.42 [1.14-1.77],0.0018388292949464
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,23682,159,1.52 [1.20-1.92],0.0004308240248694
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,25479,95,0.93 [0.65-1.33],0.7006317544796563
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,25428,44,1.03 [0.62-1.73],0.8973131056723914
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,25887,38,0.56 [0.30-1.06],0.0758903076414793
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,25542,158,1.37 [1.07-1.75],0.0134726755127959
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24320,797,1.23 [1.09-1.38],0.0005603794522534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,25946,43,0.77 [0.43-1.38],0.3835767034279066
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26586,490,1.33 [1.16-1.53],6.59636002502551e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26570,322,1.62 [1.39-1.88],7.48002919179057e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26393,544,0.90 [0.77-1.05],0.1653349671585238
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16460,289,1.27 [1.04-1.54],0.0169305965538183
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26350,267,1.47 [1.23-1.75],1.9721197310288703e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25708,324,1.09 [0.90-1.32],0.3614026576009315
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26682,434,1.29 [1.11-1.50],0.0010788848833073
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27062,591,1.20 [1.05-1.37],0.009241999583158
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,23744,221,1.03 [0.82-1.31],0.7814609079289472
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26563,315,1.63 [1.40-1.90],4.645271989778904e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26010,161,1.21 [0.94-1.57],0.1358406322392381
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26817,530,1.07 [0.93-1.24],0.3418384564274286
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26791,576,1.12 [0.97-1.28],0.1128487144825227
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26351,70,1.29 [0.91-1.84],0.1516850238042282
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26142,46,1.68 [1.12-2.50],0.0114942517978469
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26588,217,1.22 [0.98-1.52],0.080796672232557
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26512,197,1.19 [0.95-1.50],0.1333736755823699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Varicose veins,25842,458,0.95 [0.80-1.12],0.5110266307106384
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26107,97,0.91 [0.65-1.29],0.6130327641423854
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26924,691,1.18 [1.04-1.34],0.0089613512000617
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27093,215,0.91 [0.73-1.15],0.4257213974011063
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24081,1831,1.09 [1.01-1.18],0.0344445225073212
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,26525,4275,1.09 [1.04-1.15],0.0005310760525494
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27061,254,0.91 [0.74-1.12],0.3762372835262418
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24199,1949,1.10 [1.02-1.19],0.0127615444699476
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22344,94,1.12 [0.80-1.58],0.511889547739379
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,26728,1188,1.61 [1.51-1.72],1.1899588512206781e-46
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23618,1368,1.43 [1.34-1.53],1.709370051326919e-24
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Vascular dementia,26634,100,0.71 [0.49-1.02],0.0649927034096349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Alzheimer disease,27137,356,0.98 [0.81-1.18],0.8123986564712149
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",18500,58,1.18 [0.76-1.84],0.4577269898849359
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Bell's palsy,24997,85,0.98 [0.67-1.44],0.915371052560266
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25530,618,1.07 [0.93-1.23],0.3317973106072982
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral cysts,26740,220,1.10 [0.87-1.39],0.4074523006619788
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27064,274,1.20 [0.98-1.46],0.0707737504875286
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,26654,39,0.99 [0.57-1.73],0.9775096386381434
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27123,45,1.47 [0.93-2.32],0.0972164728804099
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",26573,53,1.27 [0.80-2.01],0.3044624932992213
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Epilepsy,25662,281,1.07 [0.87-1.31],0.5290570130002157
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26720,1339,1.08 [0.98-1.19],0.100083386855408
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27089,508,1.02 [0.88-1.19],0.7748354685796086
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26506,2883,1.06 [1.00-1.13],0.0681949179290675
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,26767,46,1.15 [0.70-1.87],0.580948678678533
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hemiplegia,27008,218,1.21 [0.97-1.50],0.091011254744492
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Hydrocephalus,26587,67,1.25 [0.85-1.83],0.2523387091109995
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27118,75,1.25 [0.86-1.83],0.2387762587892763
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25034,122,1.12 [0.82-1.54],0.4713245395683471
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,24976,64,1.37 [0.94-1.99],0.0973676512878247
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Memory loss,26510,96,0.72 [0.49-1.05],0.089583094829184
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Migraine,25885,504,1.12 [0.96-1.31],0.1493712890623529
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27022,453,1.12 [0.95-1.32],0.170288549846274
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Motor neuron disease,18586,119,1.04 [0.75-1.44],0.8133282663728776
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,26923,142,1.22 [0.94-1.59],0.1415957037941722
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26289,1377,1.12 [1.02-1.23],0.0164451391327925
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,25533,3770,1.08 [1.02-1.14],0.0064915595614685
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,26774,159,1.35 [1.05-1.73],0.0179495362743602
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25335,423,1.16 [0.98-1.36],0.0827371653621424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27081,230,1.05 [0.83-1.31],0.7007731104563952
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21839,660,1.10 [0.96-1.26],0.1552110051654402
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,26589,69,0.99 [0.65-1.51],0.972502116012309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,26642,122,0.97 [0.71-1.33],0.8735766572633576
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,26765,184,1.14 [0.89-1.46],0.2983401287828699
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25007,95,1.08 [0.76-1.54],0.6607038572163426
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other headache syndromes,25454,73,1.18 [0.80-1.74],0.4044570378337919
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other neurological diseases,27020,500,1.04 [0.90-1.22],0.581045514524546
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Other sleep disorders,25783,402,0.96 [0.80-1.14],0.6385216897062376
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Parkinson's disease,27113,306,1.02 [0.83-1.24],0.8585937999765683
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,26603,83,0.74 [0.49-1.12],0.1503579787701863
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,27136,103,1.09 [0.78-1.52],0.6246124787273808
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Sleep apnoea,26959,318,0.99 [0.81-1.20],0.8989923884610759
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,26891,40,1.42 [0.88-2.31],0.1549778443589241
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27127,147,1.00 [0.75-1.33],0.9953619572695208
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,24977,65,1.06 [0.69-1.64],0.7767295177195425
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27137,360,0.97 [0.80-1.17],0.7351495153503058
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),26591,97,0.72 [0.50-1.05],0.0870816884108243
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,26559,109,1.24 [0.91-1.70],0.1731308311306002
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,26680,479,1.04 [0.89-1.22],0.6161524111397539
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,26992,172,0.67 [0.50-0.89],0.0058437803198725
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26033,61,0.87 [0.55-1.38],0.5469943154516705
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26026,54,1.23 [0.78-1.95],0.3673597062299365
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27020,54,1.09 [0.68-1.74],0.7331341853545835
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,26851,164,1.02 [0.78-1.34],0.8946313582543797
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1675,38,0.88 [0.50-1.57],0.6694796682822318
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2016,68,0.95 [0.63-1.43],0.7961965180297998
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,26538,88,0.95 [0.66-1.38],0.7968974671678813
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26960,1056,0.90 [0.81-1.01],0.0803085093615483
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26718,746,1.13 [1.00-1.28],0.0534187488312159
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26265,293,1.13 [0.93-1.38],0.2197551749458097
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27044,843,1.00 [0.89-1.13],0.9527201592875782
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27120,68,1.08 [0.72-1.64],0.7010231222457497
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,26968,767,1.00 [0.88-1.14],0.9503509758059688
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27092,405,1.05 [0.89-1.25],0.5619190241979376
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27043,200,1.00 [0.78-1.28],0.990291585023654
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26012,40,1.57 [0.99-2.50],0.0548949910141515
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26019,47,0.96 [0.58-1.59],0.8668317839315518
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26037,65,1.16 [0.76-1.77],0.4949241128107209
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27049,714,1.11 [0.97-1.26],0.1235867584603169
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,26516,181,1.31 [1.03-1.66],0.0300357778632673
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26266,65,0.57 [0.35-0.92],0.0224964134479468
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,26789,102,1.00 [0.70-1.42],0.9843580705486862
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,26996,309,1.07 [0.88-1.30],0.49471391080364
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,26410,209,1.02 [0.80-1.31],0.8523100349142434
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,26974,131,1.03 [0.76-1.40],0.8539854843854817
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26803,468,1.08 [0.92-1.27],0.3316524066899016
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,26601,151,0.93 [0.70-1.24],0.6278912755861845
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25347,2470,1.00 [0.93-1.07],0.917195106228016
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,26956,269,0.96 [0.78-1.20],0.7370549100914593
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27111,153,1.21 [0.92-1.60],0.163835785007599
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26356,384,1.20 [1.01-1.42],0.0373033543378491
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,26750,63,1.00 [0.64-1.56],0.991183252052679
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27105,53,1.08 [0.67-1.73],0.7543521100843943
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26065,93,0.95 [0.65-1.37],0.7711828037184064
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26121,149,1.25 [0.96-1.63],0.092937632057665
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26010,106,0.71 [0.49-1.02],0.0671757554738974
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26272,71,1.01 [0.67-1.53],0.9540239436452044
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",25961,57,0.69 [0.42-1.15],0.1588852694055291
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,26452,117,1.03 [0.75-1.43],0.8487267517047603
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",26515,180,0.90 [0.68-1.18],0.4290214307648284
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26103,131,1.16 [0.87-1.56],0.3175039118920448
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26002,98,0.89 [0.61-1.30],0.5417537681553379
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,25979,75,1.02 [0.68-1.53],0.9215395086633624
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,24958,2081,1.07 [0.99-1.15],0.0778842487681782
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26055,83,1.09 [0.74-1.60],0.6608457036119346
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26873,423,1.02 [0.86-1.21],0.8115392370198329
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,26496,46,1.54 [1.00-2.36],0.0493520926857892
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),26616,166,1.07 [0.81-1.40],0.6442626414984469
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,26898,113,0.89 [0.63-1.25],0.4917686041915902
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27089,116,1.05 [0.76-1.45],0.7510340943302487
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27011,139,1.06 [0.79-1.42],0.6949937063297623
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,26850,65,1.30 [0.87-1.93],0.1967655805832885
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,26851,66,0.91 [0.58-1.41],0.6692178711933818
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27033,813,1.03 [0.91-1.16],0.6467518996002939
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,26779,559,1.11 [0.96-1.28],0.1698694973139093
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26343,123,0.94 [0.68-1.30],0.7197212045894527
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26306,86,0.82 [0.55-1.22],0.3222919593225489
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,26870,83,1.72 [1.26-2.33],0.0005589116427264
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27014,227,1.38 [1.12-1.70],0.0028072976008761
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,26851,64,1.50 [1.03-2.18],0.0333981592798568
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza,25436,126,1.58 [1.23-2.02],0.0002805511812975
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),25434,124,1.59 [1.24-2.04],0.000222950298735
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19286,124,1.33 [0.98-1.80],0.067457605882563
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,26987,283,0.82 [0.65-1.02],0.0710369565118946
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20999,2023,1.15 [1.07-1.24],0.0002698142576867
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21159,1997,1.15 [1.06-1.24],0.0003780548735404
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),26724,120,1.60 [1.25-2.06],0.0002354902199771
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25375,65,1.86 [1.38-2.52],5.367568053324786e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Bronchiectasis,23494,410,1.44 [1.23-1.67],3.1930422841447218e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23154,70,1.15 [0.77-1.70],0.5005017006486174
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26000,2916,1.19 [1.12-1.26],1.9368734089453483e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",25863,62,1.17 [0.76-1.80],0.4790583787322053
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,25944,143,1.19 [0.90-1.58],0.2329835988941828
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26967,1049,1.41 [1.29-1.54],6.927922057688741e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,25875,74,0.71 [0.46-1.10],0.126822018314009
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25077,5100,1.14 [1.08-1.19],1.0237683201553017e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26134,333,1.00 [0.83-1.20],0.9770369041661672
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Early onset COPD,26230,312,1.59 [1.34-1.88],1.0452646585203172e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Emphysema,23353,269,1.72 [1.45-2.03],2.200778281041598e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25536,227,2.21 [1.91-2.55],1.800497513213229e-26
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26944,1634,1.27 [1.17-1.37],2.8225314398483182e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,25573,264,2.17 [1.89-2.49],8.186159938607474e-28
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Later onset COPD,26240,737,1.38 [1.24-1.54],5.437376737696279e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27130,222,1.11 [0.89-1.39],0.3594782787774824
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,25866,65,1.06 [0.69-1.64],0.7777963013780624
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26916,908,1.19 [1.07-1.33],0.0012786367231871
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,26950,1731,1.15 [1.06-1.24],0.000664701021613
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26582,781,0.97 [0.86-1.11],0.6838937997543161
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other pleural conditions,25255,36,1.43 [0.85-2.39],0.1767198850576716
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27058,337,2.01 [1.77-2.29],3.82419484319982e-26
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27050,1169,1.15 [1.05-1.27],0.0031377261347792
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural effusion,26058,839,1.13 [1.01-1.27],0.0388200007091363
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pleural plaque,25263,44,1.08 [0.65-1.77],0.773608739709107
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26717,1407,1.26 [1.16-1.37],5.017668408446998e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27103,195,1.02 [0.80-1.30],0.8775466427024374
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pneumothorax,25307,88,1.18 [0.84-1.66],0.3287325109786753
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pollen allergy,27106,237,0.72 [0.57-0.93],0.0105387570843076
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,26782,61,1.63 [1.13-2.35],0.0085775252774232
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19214,52,1.71 [1.23-2.37],0.0013685414290701
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26892,884,1.20 [1.07-1.33],0.0014572287832365
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26084,283,0.82 [0.66-1.02],0.0746698312808546
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Viral pneumonia,25516,206,1.37 [1.10-1.70],0.004990636174047
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",26735,164,1.39 [1.09-1.78],0.0073547332953119
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13112,106,1.30 [0.95-1.79],0.0997829179781267
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19335,37,1.80 [1.16-2.81],0.0094778774869262
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute appendicitis,26951,146,1.17 [0.88-1.55],0.2694948329213602
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute gastritis,20372,91,1.37 [0.99-1.90],0.0584573809714639
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,24856,160,1.21 [0.93-1.57],0.1566234355006384
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Acute peritonitis,26572,87,1.20 [0.85-1.68],0.3039983349516468
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26264,33,1.02 [0.58-1.76],0.9568782520879108
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,20611,330,0.97 [0.80-1.18],0.7645945054124197
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",24774,78,1.02 [0.69-1.51],0.9262815405585504
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",26711,78,1.02 [0.68-1.51],0.9371811795873212
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholecystitis,24878,182,0.96 [0.74-1.25],0.7603450474032123
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Cholelithiasis,25870,1174,1.05 [0.95-1.16],0.32371198854968
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic gastritis,20618,337,1.05 [0.87-1.27],0.6064137212640637
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,24736,40,0.97 [0.56-1.70],0.923786719116816
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27054,71,1.37 [0.95-1.96],0.0911776180329623
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,25607,149,1.05 [0.78-1.41],0.7561227294457946
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Collagenous colitis,25251,111,1.41 [1.06-1.89],0.0202734378611436
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,26999,149,1.01 [0.76-1.35],0.943561803842996
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Constipation,26795,1714,1.03 [0.95-1.12],0.5080251585013076
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn disease,25234,94,1.37 [0.98-1.90],0.0619258993252213
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26781,70,1.26 [0.85-1.87],0.2455178431692284
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25237,97,1.26 [0.90-1.76],0.1761173442414424
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Dental caries,26332,228,1.05 [0.84-1.32],0.6571243077411029
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25530,2449,1.05 [0.98-1.13],0.1404976953407852
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of appendix,26994,189,1.21 [0.95-1.54],0.1320119394572409
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of liver,27035,804,1.04 [0.92-1.18],0.4953533345589307
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24855,4574,1.02 [0.97-1.07],0.535506519646816
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26677,573,1.02 [0.89-1.19],0.7394280075901185
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27013,528,1.12 [0.97-1.30],0.1268573095082646
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26217,113,0.99 [0.72-1.38],0.9682499643639582
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26069,65,0.69 [0.44-1.08],0.1066937059181356
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26841,1383,1.02 [0.93-1.12],0.7050573563294273
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of tongue,26078,110,0.89 [0.64-1.25],0.5166869411928892
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26276,1580,1.03 [0.95-1.13],0.4447868442621587
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22475,3177,1.01 [0.95-1.07],0.7750946546726074
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,20408,127,0.88 [0.64-1.21],0.4356394520564186
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27084,107,0.83 [0.58-1.19],0.3052711274302583
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27034,60,0.76 [0.46-1.24],0.2683993599769158
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26323,92,1.28 [0.92-1.78],0.1416425578147147
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19409,111,1.07 [0.77-1.49],0.6944804338260776
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,20936,655,0.98 [0.85-1.12],0.7734782416355906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastric ulcer,20626,345,1.04 [0.86-1.24],0.7096573722190417
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23046,2765,1.05 [0.98-1.12],0.1696249073968433
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20747,466,1.01 [0.86-1.18],0.9169752827459732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21214,8369,1.02 [0.98-1.06],0.2557722489968724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,GI-bleeding,26585,1127,1.02 [0.92-1.13],0.6684011391670646
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26167,63,1.04 [0.68-1.59],0.8546602925198893
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20263,1255,1.07 [0.97-1.18],0.1777468661341042
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26272,41,1.18 [0.71-1.95],0.5172223397869559
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Hernia,25958,2877,1.05 [0.99-1.12],0.1296772111855544
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impacted teeth,27044,55,0.91 [0.55-1.51],0.7272511370246635
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Impaction of intestines,19362,64,0.77 [0.48-1.22],0.2692797894518477
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Inguinal hernia,23243,162,0.91 [0.69-1.21],0.523187613762051
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19399,101,1.04 [0.73-1.48],0.8299736118102489
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25629,171,1.08 [0.82-1.41],0.5904706061972811
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20104,806,1.17 [1.03-1.32],0.0127959124970726
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27121,355,1.06 [0.88-1.27],0.5348742573292489
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,25952,812,1.13 [1.01-1.27],0.0398310800723781
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26236,1096,1.14 [1.03-1.26],0.0129715631599445
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20438,157,1.05 [0.80-1.38],0.7336445073011129
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oesophagitis,20850,569,1.13 [0.98-1.30],0.0981852328855228
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27090,154,0.94 [0.71-1.24],0.6491060077647122
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23140,59,1.35 [0.90-2.03],0.1487021002403753
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20563,1265,1.09 [0.99-1.20],0.086043748374361
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,24995,299,1.01 [0.83-1.23],0.9116124089615008
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,24888,192,0.97 [0.75-1.25],0.8246859006556619
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,20879,1581,1.16 [1.07-1.27],0.0004917716564037
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,24982,5684,1.05 [1.00-1.09],0.0613486388738257
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26070,228,0.92 [0.73-1.16],0.4718574232575595
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of liver,26907,676,0.97 [0.85-1.12],0.7047474373489411
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20849,568,1.04 [0.90-1.21],0.5670774386098143
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,24853,157,1.19 [0.91-1.54],0.1981120572578019
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,26949,464,1.10 [0.94-1.29],0.2230737087572048
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21351,1070,1.05 [0.94-1.17],0.3754085538401609
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26601,1143,1.02 [0.92-1.14],0.648322147478075
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26290,186,1.14 [0.89-1.47],0.2915018526933312
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21065,1767,1.04 [0.96-1.13],0.3678032272725074
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22387,2106,1.05 [0.98-1.13],0.1865624006469823
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26328,97,0.94 [0.65-1.34],0.7220416408837546
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26105,965,1.16 [1.04-1.29],0.0060434217892377
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19624,326,1.26 [1.06-1.52],0.0109184376755104
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27023,68,0.73 [0.45-1.16],0.181248471850547
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19787,489,1.15 [0.98-1.34],0.0825432026720824
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25585,127,0.95 [0.69-1.29],0.7249510067367616
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27128,68,1.08 [0.71-1.63],0.7190812071152586
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26104,124,1.25 [0.93-1.67],0.1347813486237666
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Toxic colitis,25206,66,1.28 [0.85-1.92],0.2320850992373945
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20514,233,0.95 [0.76-1.20],0.687121669151774
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,25304,164,0.91 [0.69-1.20],0.5074384491282375
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25275,135,0.91 [0.67-1.24],0.5576747448614139
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,23252,171,0.95 [0.72-1.24],0.7017868705934205
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19489,191,1.01 [0.79-1.30],0.9108701365612062
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Ventral hernia,23329,248,1.09 [0.88-1.34],0.4478010063009255
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Volvulus,19383,85,1.03 [0.70-1.50],0.8828291064761157
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27051,258,1.14 [0.92-1.41],0.2374440933963975
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,26820,74,0.94 [0.63-1.41],0.761904407448966
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25087,219,0.99 [0.77-1.26],0.9046418731661632
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26613,622,1.14 [1.00-1.31],0.0456910546756683
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26132,141,1.12 [0.85-1.47],0.4267778291300406
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25196,328,1.15 [0.96-1.38],0.1287915195937019
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,26825,277,1.03 [0.84-1.26],0.7941688540053937
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27027,479,1.13 [0.97-1.31],0.1298150186221158
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,26599,51,1.22 [0.76-1.95],0.4121006616148142
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25544,3142,1.15 [1.08-1.22],3.796027059492896e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26685,472,1.22 [1.05-1.42],0.0097464240154969
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26542,329,1.31 [1.10-1.57],0.0023509646870676
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26825,834,1.15 [1.02-1.29],0.0176748667283956
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27115,75,1.03 [0.68-1.57],0.8741607514034732
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,24958,90,1.46 [1.07-2.00],0.0168521465429363
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26258,45,1.08 [0.65-1.80],0.7636447978828278
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,26810,262,1.02 [0.82-1.26],0.8731003964541669
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25282,414,1.06 [0.90-1.26],0.4830292591519437
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,24914,46,1.18 [0.72-1.93],0.520453112372915
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27032,83,0.94 [0.64-1.39],0.7508117178512501
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26148,157,1.22 [0.94-1.58],0.1336024336125993
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,26910,164,1.17 [0.90-1.52],0.2378449197217388
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,26602,54,1.82 [1.29-2.56],0.0006720860941056
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,24931,63,0.85 [0.53-1.37],0.5000395154012234
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26448,1580,1.12 [1.03-1.22],0.0099639210709687
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25316,448,1.07 [0.91-1.26],0.409699172505882
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,24918,50,1.30 [0.83-2.03],0.2608133003485523
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27051,305,1.12 [0.92-1.36],0.2664343994927076
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,26630,82,1.21 [0.84-1.75],0.3085246057761441
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,26980,234,1.13 [0.90-1.40],0.2878352319347509
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27087,294,1.16 [0.95-1.42],0.1376347561335485
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25028,160,0.91 [0.68-1.22],0.533318728195466
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25128,260,0.92 [0.73-1.15],0.4609378096676865
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27073,280,1.15 [0.93-1.41],0.1991987584158442
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25064,196,1.30 [1.04-1.62],0.0219838263834222
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27100,151,1.11 [0.84-1.47],0.460738969712097
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23152,127,0.98 [0.71-1.35],0.9059427478464004
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,24662,6332,1.02 [0.98-1.07],0.3506736524490945
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23274,4944,1.01 [0.96-1.06],0.6792723269876957
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23100,75,0.78 [0.50-1.20],0.2559390859569925
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23270,152,1.35 [1.05-1.74],0.0213353544151877
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23326,208,0.87 [0.68-1.12],0.291992924706761
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,26848,113,1.15 [0.83-1.58],0.412609220509495
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23232,114,1.24 [0.92-1.67],0.1602966113422998
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19693,1363,1.05 [0.96-1.16],0.2893028213294302
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",26985,220,0.88 [0.69-1.11],0.2819617742531363
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23725,607,1.04 [0.91-1.20],0.5501656102413178
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22820,8037,1.00 [0.96-1.04],0.9097998778142792
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24310,137,0.97 [0.71-1.31],0.8178799310293434
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23156,131,0.97 [0.72-1.31],0.835303773628767
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23709,684,0.96 [0.83-1.10],0.5392463255910962
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26125,3007,1.07 [1.01-1.14],0.0241860668790938
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23198,173,0.99 [0.76-1.29],0.9396079633315808
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23396,371,1.10 [0.92-1.31],0.2952131587296716
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23192,167,0.78 [0.58-1.04],0.0907314817364718
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26207,102,1.01 [0.71-1.42],0.967812436549874
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20189,1859,0.97 [0.89-1.05],0.4415629817883308
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18552,222,1.20 [0.97-1.49],0.1004628004366837
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27125,219,1.21 [0.97-1.51],0.0887552871383278
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18427,97,0.96 [0.66-1.39],0.813003365682273
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18904,574,0.97 [0.84-1.13],0.7168643086239281
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23358,333,0.81 [0.66-0.99],0.0440387186691738
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18956,626,0.98 [0.85-1.13],0.7451994888320677
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23186,68,1.27 [0.86-1.87],0.2286984939005479
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23825,707,1.15 [1.02-1.30],0.0264359747248555
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23453,335,1.28 [1.07-1.53],0.0070338158684633
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18914,584,0.96 [0.82-1.11],0.5651824253002241
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23115,90,1.03 [0.71-1.49],0.8771465404488724
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23094,69,0.95 [0.62-1.46],0.8119950435429035
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24219,46,1.19 [0.73-1.94],0.4805300103684361
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26660,2487,1.05 [0.98-1.12],0.2026384619283063
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25970,1797,1.04 [0.96-1.13],0.3221756561035123
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26937,604,1.30 [1.14-1.48],6.723292672847443e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21341,3011,1.07 [1.01-1.14],0.030753628478258
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18402,72,1.18 [0.79-1.78],0.4200195987984731
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23126,101,0.99 [0.70-1.41],0.9675463142342186
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18373,43,1.25 [0.76-2.07],0.3755806568422836
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18531,201,0.83 [0.64-1.08],0.1617421126763543
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24461,288,1.02 [0.83-1.26],0.8400900380423931
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,24756,583,1.04 [0.90-1.21],0.5545724048166694
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27106,112,0.93 [0.66-1.30],0.6531503879649192
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25140,2022,1.11 [1.03-1.20],0.0066828959167014
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23156,131,0.98 [0.71-1.33],0.8800058189916908
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18560,230,0.96 [0.75-1.22],0.7252102697797947
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23932,814,1.14 [1.02-1.29],0.0264239828388223
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20845,2515,1.00 [0.93-1.07],0.9762386850111516
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26230,125,1.25 [0.94-1.68],0.1272673402577723
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27117,74,0.95 [0.64-1.43],0.8168462589561243
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23106,81,1.03 [0.71-1.50],0.8707527074615805
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24484,1459,1.04 [0.95-1.14],0.3743349453185934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23106,81,1.05 [0.72-1.52],0.8070131368749766
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20309,1979,1.14 [1.05-1.23],0.0010364180823161
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24307,134,1.05 [0.78-1.41],0.7685704199350285
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23089,64,1.02 [0.65-1.60],0.9336812835926254
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23311,193,1.06 [0.83-1.35],0.658777048163891
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23609,584,1.05 [0.91-1.21],0.5118947413993129
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26603,498,1.21 [1.04-1.40],0.0144048151303852
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23762,644,1.09 [0.95-1.24],0.2058474306445364
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,26952,585,1.28 [1.12-1.46],0.0003144514755763
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27107,69,1.26 [0.85-1.87],0.2564165914451348
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23251,226,1.01 [0.80-1.28],0.9254499908673064
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20821,901,1.10 [0.98-1.23],0.1079040887168714
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23690,665,1.06 [0.93-1.21],0.3810260107078194
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23148,123,1.00 [0.73-1.37],0.9868478286725546
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18406,76,0.94 [0.63-1.41],0.7614149447573384
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20960,2630,1.12 [1.05-1.19],0.0010311008227769
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19164,834,1.01 [0.90-1.15],0.8166721578372522
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26398,293,1.15 [0.94-1.40],0.1746476765934212
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27079,85,1.03 [0.71-1.51],0.8649265857768265
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",24859,53,0.83 [0.51-1.36],0.4608560450997897
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18404,74,0.97 [0.65-1.46],0.9010185732483325
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23231,113,1.30 [0.97-1.75],0.078316322383769
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18937,607,1.29 [1.13-1.47],0.0001354413601554
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23359,334,1.05 [0.87-1.27],0.6330764241955265
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23400,282,1.21 [1.00-1.47],0.0532965889572895
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23400,282,1.07 [0.87-1.31],0.5070916740036076
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20969,87,1.34 [0.95-1.89],0.1010190889054756
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27114,76,1.25 [0.86-1.82],0.2437613245316683
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23665,640,0.93 [0.80-1.07],0.298334095505899
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],26265,160,1.55 [1.22-1.97],0.0003391381683989
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25821,2796,1.00 [0.93-1.07],0.9523318703425548
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23182,157,1.24 [0.96-1.61],0.1027301437155527
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23697,579,1.19 [1.04-1.37],0.0116250206347934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,25436,258,1.02 [0.82-1.26],0.8861063453800266
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23393,275,1.10 [0.90-1.35],0.3387007374259875
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24875,1757,1.12 [1.03-1.21],0.0061108179835536
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24314,1196,1.15 [1.05-1.27],0.0042400768726748
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23088,63,1.11 [0.73-1.69],0.636852554163162
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26323,218,1.24 [0.99-1.55],0.0643603406897991
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23226,201,1.09 [0.85-1.39],0.4924001303172673
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23153,128,1.14 [0.84-1.53],0.4048548378378264
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18384,54,1.34 [0.86-2.09],0.2002915092757517
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26070,1240,1.23 [1.12-1.35],8.403783459541743e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20292,100,0.84 [0.58-1.23],0.3761366750507114
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26439,112,1.00 [0.71-1.40],0.9973995635797605
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,26976,233,1.09 [0.87-1.37],0.4374993153795593
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,26770,27,0.73 [0.34-1.56],0.4213514407691817
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26307,1477,1.21 [1.11-1.32],9.832413105341466e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,26962,79,1.38 [0.98-1.95],0.0652367219052246
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,26929,242,0.94 [0.75-1.18],0.6113031784396707
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Cystitis,23944,254,0.94 [0.75-1.18],0.6014016333587511
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dialysis,24883,53,1.10 [0.68-1.78],0.6945255386854976
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26666,339,1.07 [0.89-1.29],0.4789884961898829
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20368,176,1.04 [0.79-1.35],0.7969312174646692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20583,391,1.05 [0.88-1.26],0.5931738375093054
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21189,997,0.91 [0.81-1.02],0.1105515916350149
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21121,5020,1.02 [0.97-1.07],0.4219753118303072
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,26949,66,1.47 [1.01-2.15],0.0441190010359888
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,24708,207,0.77 [0.60-1.00],0.0514853432294927
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26597,393,1.04 [0.87-1.24],0.6542296271709709
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,26670,126,1.12 [0.82-1.53],0.4622455907238749
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20493,301,1.01 [0.82-1.25],0.9026618531425944
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23767,77,0.86 [0.57-1.30],0.4801991576306907
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22629,2437,0.99 [0.92-1.06],0.7693836613684505
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20332,140,0.91 [0.67-1.24],0.539137539289233
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27122,65,0.73 [0.45-1.18],0.2037813887999814
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27126,73,1.04 [0.70-1.56],0.8319141053543059
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25906,2216,1.04 [0.97-1.12],0.3005020904351622
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24154,464,1.10 [0.94-1.29],0.2277644227467123
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26444,117,0.98 [0.71-1.37],0.911777662515746
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27075,388,1.06 [0.90-1.26],0.4774945939164554
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27076,91,0.76 [0.51-1.13],0.1701848005755678
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25595,1905,1.05 [0.97-1.14],0.2090411588524342
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26402,198,1.16 [0.91-1.48],0.2268337211687562
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20346,154,1.04 [0.78-1.38],0.7929337361843934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20557,365,1.03 [0.86-1.24],0.7451067229714857
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20300,108,0.95 [0.68-1.34],0.7700969730420543
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20398,206,1.31 [1.05-1.64],0.0175492155158297
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24761,260,0.71 [0.56-0.90],0.0041056929362244
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,26812,125,1.17 [0.88-1.56],0.2895421425104238
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20501,309,1.03 [0.84-1.26],0.7692744246894405
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20297,105,1.04 [0.73-1.47],0.8369212510765862
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20826,634,1.08 [0.94-1.25],0.2514625596402705
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20351,159,0.90 [0.68-1.21],0.4920849552200431
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20778,586,1.05 [0.91-1.22],0.4864470871089457
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,26922,39,1.58 [0.99-2.50],0.0528307766486813
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26944,2443,1.15 [1.08-1.23],4.596995185538631e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",24661,160,1.21 [0.92-1.58],0.1672801814009514
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,24934,104,1.30 [0.96-1.77],0.0915083639047192
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26776,33,1.32 [0.76-2.30],0.3221440443195055
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23836,146,1.33 [1.02-1.73],0.0362563797767888
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27009,266,1.15 [0.94-1.41],0.1801627297657909
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20328,136,1.05 [0.78-1.42],0.7434816225936424
